Q2 2020 Holdings
Filed 2020-08-14 | 143 holdings | $788.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centene Corp del(CNC) | COM | 15135B101 | $83.6M | 1,315,000 | 10.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $64.8M | 287,500 | 8.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $63.1M | 1,179,720 | 8.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $51.1M | 1,055,000 | 6.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $51.1M | 345,000 | 6.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $48.2M | 180,000 | 6.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $47.8M | 387,500 | 6.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $40.5M | 215,000 | 5.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $39.2M | 143,000 | 5.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $38.6M | 1,100,000 | 4.9% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $36.2M | 2,025,275 | 4.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $34.7M | 5,015,109 | 4.4% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $31.6M | 213,500 | 4.0% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $27.8M | 575,000 | 3.5% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $22.6M | 900,000 | 2.9% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $20.6M | 1,175,000 | 2.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $19.9M | 1,986,910 | 2.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $18.9M | 440,468 | 2.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $16.1M | 481,468 | 2.0% |
| Conmed Corp(CNMD) | COM | 207410101 | $13.0M | 180,000 | 1.6% |
| Bright Horizons FAM SOL in D(BFAM) | COM | 109194100 | $11.5M | 98,500 | 1.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.7M | 1,644,015 | 0.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.8M | 77,417 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $166.7K | 1,366,500 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $119.5K | 405,000 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $75.4K | 651,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $74.9K | 960,029 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $74.1K | 191,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $68.4K | 120,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $66.8K | 813,246 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $59.5K | 1,677,679 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $56.9K | 293,000 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $55.5K | 645,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $55.4K | 345,500 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $53.3K | 549,500 | 0.0% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $51.6K | 832,500 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $50.6K | 646,841 | 0.0% |
| Pacira Biosciences(PCRX) | COM | 695127100 | $48.5K | 925,000 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $47.6K | 570,598 | 0.0% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $47.3K | 130,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $46.1K | 386,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $45.8K | 1,511,127 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $44.0K | 1,878,428 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $42.5K | 250,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $41.5K | 2,306,196 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $41.3K | 125,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $40.2K | 582,000 | 0.0% |
| Freshpet Inc(FRPT) | COM | 358039105 | $39.8K | 476,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $39.8K | 348,761 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $37.0K | 207,000 | 0.0% |